“2025 was a period of intensive preparation for us. We streamlined corporate matters, built our target organizational structure, and prepared the company to operate as an independent public entity. A key priority was to execute the spin-off in a way that ensured full business continuity, including the transfer of competencies, teams, projects, and intellectual property. At the same time, we continued to develop technologies and run R&D projects within the spun-off segment, ensuring that upon completion we had not only a well-structured organization but also a ready product pipeline. This allowed us to enter 2026 prepared to transition from the organizational phase to full operations and begin commercialization, particularly in the area of quantum key distribution,” said Dr. Anna Kamińska, President of the Management Board of Creotech Quantum S.A.
Creotech Quantum S.A. was formally established in June 2025 as a special-purpose entity created to take over quantum technology activities from Creotech Instruments. In August 2025, the demerger plan was adopted, followed by intensive organizational and legal preparations, including the prospectus approval process by the Polish Financial Supervision Authority. As of the end of 2025, the spin-off process was still ongoing.
The prospectus related to the issuance of demerger shares was approved after the reporting period, on February 18, 2026. The main phase of the spin-off was completed on April 1, 2026, and the company debuted on the WSE on April 17, 2026. This marked the first public listing in Europe of a company focused on the development and commercialization of quantum technologies.
The IPO represented a major milestone not only for the company but also for the Polish and broader European deep-tech ecosystem. It confirmed Creotech Quantum’s readiness to operate as an independent public company and reflected the growing maturity of quantum technologies, which are now entering the commercialization phase. The event also aligns with Europe’s broader ambition—including Poland’s—to build a strong position in breakthrough technologies.
Following the spin-off, the company continues to finalize its shareholder structure.
“From a capitalization perspective, we are currently implementing corporate actions aimed at establishing our final shareholder structure. At present, Creotech Instruments holds 1,500,000 shares, representing 34.45% of the share capital and voting rights. However, this is a temporary arrangement to facilitate the demerger process. The redemption of Series A shares is currently underway in accordance with the redemption agreement. As a result, Creotech Instruments will ultimately not remain a shareholder, and we expect the currently held shares to be redeemed in the second half of 2026,” added Dr. Anna Kamińska.
In 2025, Creotech Quantum did not yet conduct operational activities in quantum technologies, as these were still carried out within Creotech Instruments under the spun-off segment.
Key achievements in 2025 included significant progress toward commercialization and the reduction of technological risks in critical areas.
In the field of quantum key distribution (QKD), the company developed, manufactured, and demonstrated the first prototypes of ground-based systems in an operational environment within a pilot urban network in Vienna, as part of the eCAUSIS project. This milestone provides a direct foundation for market entry in 2026.
At the same time, projects carried out for the European Space Agency (QKD HRDP and LAND) delivered significant progress in single-photon detection technologies for ground-based QKD stations. These capabilities strengthen the company’s product development potential and represent an important step toward entering the satellite quantum communication market.
Another important milestone was the signing of a contract for the PIONIER-Q-SAT project, implemented within a consortium led by NASK. The project involves the development of a cross-border QKD link using a mobile optical ground station, enabling the demonstration of key system components and the development of integration capabilities, including for satellite communication.
The company also advanced complementary technologies with strong market potential. In the area of ultra-precise time synchronization, it secured a project from the European Space Agency focused on the application of White Rabbit technology in private 5G mmWave infrastructure.
In the advanced imaging segment, the company signed a contract with the European Space Agency for the “Telescope Array Functional Prototype” project, enabling the demonstration of its astronomical camera for space situational awareness and orbital monitoring applications.
The activities carried out in 2025 confirm the effectiveness of the company’s strategy, based on intellectual property development, real-world technology demonstrations, and a gradual transition toward commercialization. QKD remains the key focus area, offering the greatest potential for scaling operations.
The outcomes of 2025 provide a direct foundation for 2026 objectives, including the market launch of ground-based QKD systems, pilot deployments with early customers, and further expansion of the product portfolio.
Creotech Quantum’s long-term goal is to become one of the leading players in the European quantum technology market and to actively contribute to its large-scale commercialization.
